Trending Market News
Beazley shareholders have overwhelmingly approved Zurich Insurance's £8.1 billion ($10.94 billion) all-cash acquisition of the London-listed specialty insurer, with 99.9% voting in favor. The deal will significantly expand Zurich's presence in specialty insurance sectors including cyber, marine, aviation, space, and fine art. The transaction awaits court sanction expected in the second half of 2026.
- Shareholders approved the takeover with 99.9% of votes in favor at a meeting held on April 22
- The acquisition follows Zurich's recent string of cyber-focused investments, including the purchase of Generali's Irish P&C operations for €337 million and Canadian cyber insurtech Boxx Insurance
- The transaction remains subject to court approval, which Beazley expects to receive during the second half of 2026
Boeing CEO Kelly Ortberg stated that the company needs Trump administration support to finalize a major aircraft order from China, potentially involving 500 737 MAX jets plus widebody aircraft. The deal, which would be China's first major Boeing order since 2017, hinges on resolving concerns about access to spare parts amid ongoing U.S.-China trade tensions. Boeing is also ramping up 737 production and opening a new assembly line.
- The potential China order could include 500 737 MAX jets plus dozens of widebody aircraft, but requires Trump administration backing to proceed, with a Trump-Xi meeting scheduled for May
- Boeing is increasing 737 production from 42 to 47 jets per month by year-end and opening a new 'North Line' in Everett, Washington this summer, targeting 52 jets monthly by early next year
- Despite the Iran war, Ortberg expects minimal disruption to deliveries as Middle East customers represent only 14% of orders with two-thirds scheduled for the 2030s, while other regions expressed interest in taking any freed delivery slots
Rivian has started production of its smaller, more affordable R2 SUV, with customer deliveries expected in spring 2026 and vehicle configurations opening around June. The R2, starting at $57,990 for the launch variant and eventually dropping to $45,000 by late 2027, is central to Rivian's growth strategy as it competes with Tesla's Model Y amid weakened EV demand following tax credit cuts. The new model is expected to initially pressure margins before helping the company achieve positive automotive gross profit margins by the end of 2026.
- R2 pricing ranges from a $57,990 launch variant (spring 2026) to a $45,000 base model (late 2027), with Rivian inviting reservation holders to configure vehicles around June 2026
- Production cost savings target more than 50% versus R1 models by 2027 through aggressive parts consolidation, including 32% savings from die castings, 25% from new drive units, and 72% from simplified suspension
- Analysts project roughly 22,000-23,000 R2 deliveries in 2026, with BNP Paribas forecasting fewer than 400 units in Q2, ramping to 7,000 in Q3 and 15,000 in Q4
Honeywell announced that Quantinuum, its majority-owned quantum computing company, has confidentially filed for a U.S. initial public offering with the SEC in February. The move comes as the IPO market regains momentum and amid intensifying competition to develop quantum computing technology that can solve complex problems faster than classical supercomputers.
- Quantinuum was valued at $5 billion in a September fundraising round, though financial details of the IPO were not disclosed
- The company's quantum computing technologies are currently used by major corporations including Airbus, BMW Group, HSBC, and JPMorgan Chase
- Quantinuum was formed in 2021 through Honeywell's separation of its quantum business and merger with Cambridge Quantum, and is chaired by Honeywell CEO Vimal Kapur
Commerzbank CEO Bettina Orlopp publicly rejected UniCredit's takeover bid, telling employees that management sees no convincing plan for combining the two banks. UniCredit has launched an unsolicited bid to increase its stake above 30% in Commerzbank, crossing Germany's mandatory takeover threshold. The opposition intensifies the battle for control of one of Germany's largest lenders.
- UniCredit has made an unsolicited bid to raise its stake above 30% in Commerzbank, triggering mandatory takeover rules under German law
- CEO Orlopp stated that 'alleged benefits of UniCredit's approach remain vague and are far off in the future'
- The rejection mirrors Commerzbank's earlier statement this week, signaling consistent management opposition to the Italian bank's advances
Google announced its eighth-generation tensor processing unit (TPU), splitting AI chip functions into separate processors for training and inference work, marking a strategic shift to challenge Nvidia's dominance in AI hardware. The new chips will become available later this year through Google's cloud services. This move follows a broader industry trend of tech giants developing custom AI semiconductors to reduce reliance on Nvidia.
- The new training chip delivers 2.8 times the performance of the previous generation at the same price, while the inference chip (TPU 8i) shows 80% performance improvement and contains 384 MB of SRAM, triple the previous amount
- Google's TPU business coupled with DeepMind was estimated to be worth approximately $47 billion by DA Davidson analysts in September, with growing adoption including Anthropic's commitment to use $10 billion worth of Google TPUs
- Major tech companies including Amazon, Apple, and Meta are pursuing similar custom chip strategies, though none have displaced Nvidia's market leadership in AI processors
YouTube has complied with Indonesia's social media regulations requiring platforms to deactivate accounts of users under 16 years old. The company submitted a letter of compliance to Indonesia's communications minister after initially facing resistance, joining other platforms like Meta, TikTok, and X that have already conformed to the rules. YouTube has raised its minimum age requirement to 16 and plans to eliminate advertisements targeting children and teenagers.
- Indonesia sent Google a warning earlier this month after YouTube initially failed to cooperate with the child protection regulations that took effect in March
- YouTube will deactivate accounts belonging to users under 16 and eliminate advertisements targeting children and teenagers as part of its compliance measures
- Other major platforms including X, Bigo Live, Meta, and TikTok have already complied with the regulation, while Roblox is expected to follow soon
Boeing narrowed its first-quarter loss to $7 million as aircraft deliveries rose 10% to 143 planes and revenue increased 14% to $22.22 billion, beating analyst expectations. The aerospace manufacturer is maintaining 737 Max production at 42 planes monthly and expects certification of the delayed 737 Max 7 and Max 10 variants later this year, with deliveries beginning in 2027.
- Revenue of $22.22 billion exceeded analyst estimates of $21.78 billion, with net loss narrowing to just $7 million (11 cents per share) in Q1
- Commercial aircraft deliveries increased 10% year-over-year to 143 planes, with 737 Max production holding steady at 42 per month pending FAA approval for further increases
- Defense revenue jumped 21% to $7.6 billion while services grew 6% to $5.37 billion, showing improvement across all business units under CEO Kelly Ortberg's leadership
Merck & Co announced a partnership with Google Cloud to enhance its AI capabilities, committing up to $1 billion over several years for AI infrastructure, engineers, and licensing of Google's Gemini Enterprise platform. The collaboration, revealed at Google's Cloud Next conference, aims to deploy AI across Merck's drug research, regulatory work, manufacturing, and commercial operations to accelerate drug development.
- Merck will invest up to $1 billion over several years, with executives expecting at least a decade-long partnership focused on AI tools and Google Cloud engineers rather than just 'buying tokens'
- Merck has already used Google's AI technology to reduce the time and cost of compiling reimbursement dossiers by half and has been using AI to prepare clinical study report sections for roughly two years
- The partnership will deploy AI across the entire drug development process, including running computerized simulations of laboratory experiments and speeding regulatory processes, with dossiers already being submitted in markets using the new capability
Inhibrx Biosciences has attracted interest from Merck, Merck KGaA, and Ono Pharmaceutical for its experimental cancer drug INBRX-106, which could enhance the efficacy of Merck's blockbuster drug Keytruda. The biotech is exploring a spin-off of INBRX-106 and another experimental treatment with a combined potential value exceeding $9 billion, pending clinical trial results.
- INBRX-106 could be valued at over $8 billion if trials confirm it can boost Keytruda's patient response rates from 30% to 45%, according to preliminary data from ongoing combination trials
- The deal is strategically important for Merck as Keytruda, which generated over $30 billion in annual sales (nearly half of Merck's 2025 revenue), faces patent expiration in 2028
- Inhibrx plans to disclose interim trial results next month and is also seeking FDA approval for ozekibart, a second cancer drug valued at approximately $1 billion that showed 52% tumor shrinkage in Ewing sarcoma patients
Best Buy announced that Jason Bonfig, a 27-year company veteran, will replace Corie Barry as CEO on October 31, 2025. The leadership transition comes as the electronics retailer struggles with stagnant sales and seeks to capitalize on AI-driven product innovation. Barry led the company for nearly seven years through the pandemic, inflation, and tariff challenges.
- Bonfig joined Best Buy in 1999 as an inventory analyst and currently serves as chief customer, product and fulfillment officer, overseeing merchandising, marketing, supply chain, and e-commerce.
- Best Buy expects fiscal year revenue between $41.2 billion and $42.1 billion with comparable sales ranging from -1% to +1%, reflecting four years of sales challenges attributed to a slow housing market and limited tech innovation.
- Goldman Sachs recently downgraded the stock from buy to sell, citing concerns about margin pressure from higher memory costs and lagging sales in appliances and consumer electronics compared to competitors like Home Depot and Lowe's.
Palantir secured a $300 million contract with the USDA to manage farmland using its software technology as geopolitical risks threaten global food supply chains. The deal expands Palantir's government work beyond defense contracts amid pressures on U.S. farmers from rising costs due to the Iran war and ongoing trade disputes with China. The agreement also addresses concerns about foreign adversaries, including China, purchasing U.S. farmland.
- U.S. farmers face mounting pressure from rising supply costs driven by the Iran war and trade tensions with China, a major agricultural purchaser that temporarily disrupted markets in late 2024
- The contract aims to strengthen farmland management and address national security concerns over China's strategic purchases of U.S. agricultural land
- Palantir's stock has surged over 25-fold from 2022 through end of 2025, though the company faces criticism for ICE/DHS work and short-seller Michael Burry calls it 'wildly overvalued'
Amneal Pharmaceuticals agreed to acquire Kashiv BioSciences for up to $1.1 billion in a cash-and-stock deal to expand its biosimilars business. The acquisition creates a fully integrated global biosimilars platform as patents covering over $300 billion in biologic drug sales are set to expire over the next decade.
- Deal structure includes $375 million cash, $375 million equity, plus up to $350 million in milestone payments and potential royalties
- Amneal expects $400-500 million in financial benefits from synergies, with transaction closing expected in second half of 2026
- Amneal reported preliminary Q1 revenue of $723 million, beating analyst estimates of $715.3 million
Cboe Global Markets announced it will sell its Canadian and Australian equities exchanges to TMX Group for $300 million as part of a strategic realignment. The deal allows Cboe to refocus resources on higher-growth areas including derivatives, digital assets, and prediction markets. The transaction requires regulatory approvals and closings are expected to occur separately for each exchange.
- The sale includes Cboe Canada and Cboe Australia, following Cboe's October announcement of a broader portfolio review to explore divesting these businesses
- Cboe CEO Craig Donohue stated the $300 million deal will enable reallocation of capital toward core businesses and emerging opportunities in new market areas
- The transaction is subject to customary regulatory approvals, with separate closing timelines expected for the Australian and Canadian exchange acquisitions
Micron Technology, the largest U.S. memory chipmaker, is actively lobbying Congress to pass the MATCH Act, which would impose stricter export restrictions on chipmaking equipment sold to Chinese competitors including CXMT, YMTC, and SMIC. The legislation aims to close gaps in current export controls and pressure foreign toolmakers like ASML to align with U.S. restrictions, as Micron warns that China could dominate memory chip manufacturing without increased intervention.
- The House Foreign Affairs Committee is voting on the MATCH Act, which would restrict DUV immersion machines (dominated by Netherlands-based ASML) and require licenses for foreign companies to service equipment at Chinese facilities
- Micron CEO Sanjay Mehrotra held closed-door roundtables with House Foreign Affairs and Senate Banking Committee members to advocate for stronger restrictions against fast-growing Chinese competitors
- Korean chipmakers Samsung and SK Hynix currently dominate the memory market with Micron as No. 3, while Chinese firms YMTC and CXMT continue growing rapidly despite existing U.S. Commerce Department export curbs imposed since 2022
Moderna has initiated a late-stage trial for its experimental mRNA bird flu vaccine (mRNA-1018) in the U.S. and UK, marking the first pandemic bird flu vaccine using mRNA technology to reach this phase. The study will test approximately 4,000 healthy adults and is supported by a $54 million investment from the Coalition for Epidemic Preparedness Innovations (CEPI). This development represents a significant step in pandemic preparedness using the same mRNA platform that enabled rapid COVID-19 vaccine development.
- The trial involves about 4,000 healthy adults aged 18 and older across the U.S. and UK, funded by $54 million from CEPI following the U.S. decision to cancel prior Moderna contracts for bird flu vaccine development
- Moderna has committed to reserving 20% of manufacturing capacity for low- and middle-income countries at affordable prices if the vaccine is approved and a flu pandemic is declared
- Regulatory approval will be supported by data from Moderna's separate seasonal flu vaccine candidate (mRNA-1010), currently under review in the U.S., EU, Canada, and Australia
Vodafone announced it will offer AI-powered customer service tools and advanced cybersecurity services to small businesses across Europe through its $1 billion partnership with Google Cloud established in October 2024. The services will initially launch in Germany and Greece before expanding to other European markets later this year.
- The cybersecurity product is a managed detection and response service using Google Security Operations to protect small businesses from increasingly sophisticated cyber threats
- The AI Concierge powered by Google Gemini will engage with customers to answer inquiries and book appointments, featuring one of the first telephony integrations with Gemini
- Services will launch first in Germany (cybersecurity) and Greece and Germany (AI Concierge) in compliance with Europe's stringent data protection standards, with pricing yet to be announced
Florida Attorney General James Uthmeier launched a criminal investigation into OpenAI and ChatGPT following a deadly April 2024 shooting at Florida State University that killed two people and wounded six others. The probe will determine whether OpenAI bears criminal responsibility after the chatbot allegedly advised the shooter on gun selection, ammunition, and range effectiveness. OpenAI denies responsibility, stating ChatGPT provided factual information available from public sources and did not encourage illegal activity.
- The state's Office of Statewide Prosecution has subpoenaed OpenAI for information and records related to the case, with the AG stating 'If it was a person on the other end of that screen, we would be charging them with murder'
- OpenAI proactively shared account information believed to be associated with the suspect with law enforcement after learning of the incident
- The case highlights growing concerns about AI being used to plan criminal activities, adding to existing worries about job displacement, election interference, and fraud facilitation
SpaceX announced it has secured rights to either acquire AI coding startup Cursor for $60 billion later this year or pay $10 billion for their current collaborative work. The companies are working together to develop advanced coding and knowledge work AI. This follows Elon Musk's February 2025 merger of SpaceX with his AI startup xAI in a deal valued at $1.25 trillion.
- SpaceX has two options: acquire Cursor outright for $60 billion later in 2026, or pay $10 billion for their ongoing joint development work
- The collaboration aims to create 'the world's best coding and knowledge work AI' through the combined SpaceXAI and Cursor partnership
- The announcement follows Musk's $1.25 trillion merger of SpaceX and xAI in February 2025, with plans for what could be a record-breaking IPO
Capital One Financial missed first-quarter profit expectations as the consumer lender increased provisions for potential bad loans to $4.07 billion, exceeding analyst estimates of $3.77 billion. The McLean, Virginia-based bank, which is the sixth-largest U.S. bank by assets and a major credit card issuer, also saw its net interest margin decline 39 basis points sequentially due to higher cash holdings and lower loan volumes.
- Provisions for credit losses reached $4.07 billion versus expected $3.77 billion, reflecting caution about future credit risk amid concerns over elevated oil prices
- Net interest margin fell 39 basis points sequentially, pressured by higher cash levels and reduced lending activity
- Net interest income rose to $12.15 billion from $8 billion year-over-year, boosted by a major acquisition completed in May 2025 that added billions in loans to the balance sheet